ctrl K

Talis Biomedical Corporat... (TLIS)

OTC: TLIS · Real-Time Price · USD

1.06

-0.54 (-33.75%)

At close: Apr 04, 2025, 9:37 AM

Talis Biomedical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	412K	3.65M	n/a	10.94M	3.98M	2.39M
Cost of Revenue	41K	8.39M	2.62M	n/a	n/a	n/a
Gross Profit	371K	-4.74M	-2.62M	10.94M	3.98M	2.39M
Operating Income	-66.81M	-115.14M	-191.82M	-91.18M	-26.7M	-21.43M
Interest Income	n/a	n/a	n/a	54K	42K	93K
Pretax Income	-62.01M	-113.01M	-192.04M	-91.13M	-27.47M	-21.34M
Net Income	-62.01M	-110.89M	-190.46M	-91.08M	-27.43M	-21.34M
Selling & General & Admin	28.21M	40.73M	42.42M	13.1M	6.86M	5.43M
Research & Development	40.69M	70.83M	157.59M	89.02M	23.81M	18.39M
Other Expenses	-1.72M	-1.16M	-8.19M	-10.94M	-3.98M	n/a
Operating Expenses	67.19M	110.4M	191.82M	91.18M	26.7M	21.43M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	67.23M	118.79M	191.82M	91.18M	26.7M	21.43M
Income Tax Expense	n/a	-2.13M	-1.58M	-54K	-42K	93K
Shares Outstanding (Basic)	1.82M	1.78M	1.51M	290K	150K	150.42K
Shares Outstanding (Diluted)	1.82M	1.78M	1.51M	290K	150K	150.42K
EPS (Basic)	-34.12	-62.45	-126.13	-314.06	-182.88	-141.85
EPS (Diluted)	-34.12	-62.45	-126.13	-314.06	-182.88	-141.85
EBITDA	-66.05M	-106.31M	-191.82M	-90.42M	-25.97M	-20.78M
EBIT	-66.81M	-115.14M	n/a	n/a	n/a	n/a
Depreciation & Amortization	770K	11.6M	2.62M	1.37M	726K	647K